CBD and Nutraceutical Merchant Accounts: How to Get Approved and Stay Approved

The closure email usually arrives on an ordinary weekday and runs about four sentences. The account is closed effective immediately, under a clause of the terms nobody reads at signup. The remaining balance is held for a window described vaguely enough that you cannot plan around it. Nothing about the catalog changed that week, and nothing about the order pattern changed either. What changed is that somebody finally looked at the account properly. CBD, supplements and nutraceuticals sit in the same uncomfortable spot as peptides and research compounds: legal to sell in most places, bought constantly, and still priced by banks as a risk they would rather not carry. This guide covers why these categories are underwritten as high risk, what a reviewer actually looks at, and how to set up processing and a storefront that survive the review instead of triggering it.

Why CBD is high risk

In the United States, hemp-derived CBD became legal at the federal level when the 2018 Farm Bill removed hemp from the controlled substances list, as long as it stays under the THC limit. That did not settle everything. The FDA has not approved CBD as a dietary supplement or a food additive, state rules differ, and product testing is uneven across the market. For an acquiring bank, that means legal ambiguity, a real chance of mislabeled product, and customers who sometimes dispute charges they do not recognize on a statement.

This is also an area where the rules keep moving. Federal hemp provisions, state-level restrictions on intoxicating hemp products and individual acquirer policies have all shifted more than once since the Farm Bill passed, usually in the restrictive direction. Treat any specific threshold you read, here or anywhere else, as something to confirm against the current rule and your own counsel rather than as settled ground.

Card networks allow hemp-derived CBD, but acquirers decide for themselves whether to carry it, and many mainstream processors still do not. Ingestible products and topicals are often treated differently, and anything making a medical claim draws far more scrutiny than a plainly described product.

Why nutraceuticals and supplements are high risk

For supplements and nutraceuticals the risk is less about legality and more about how the products are sold. The classic problem is the free trial that rolls into a subscription the customer did not expect. Those orders turn into disputes, and the card networks responded with rules that require clear consent to the subscription, a reminder before the first full charge, and an easy way to cancel. Stores that sell this way, or that make strong health claims, get reviewed hard. A store that sells one-time purchases with plain descriptions and honest delivery times is a much easier account to place.

The same logic applies to peptides and research compounds, with the added problem that many acquirers will not take research-use-only products at all. If your catalog mixes categories, assume the account gets underwritten against the hardest thing in it, not the average.

What a reviewer checks

Expect to be asked for, or judged on, most of the following:

• Your product claims. Treatment, cure or disease language is the fastest route to a decline. Describe what the product is, not what it fixes.
• Lab documentation. Certificates of analysis for each product, ideally from a third-party lab, and for CBD, proof the THC content is within the legal limit.
• Your policies. A clear refund policy, shipping times, terms of service and contact details that a customer can actually find.
• How you bill. One-time orders, subscriptions or trials, and how cancellation works.
• Your history. Processing statements, dispute ratios and any past terminations.
• Your volume. Some acquirers set monthly volume minimums and want months of history before they will look at a new merchant.

The high-risk underwriting checklist has the full document list, and refund policy pages that reduce disputes covers the page reviewers read most closely.

What the reviewer sees before you send a single document

The part merchants underestimate is that underwriting starts on your website, not in your application. A reviewer opens the storefront, reads a few product pages, checks whether the policies exist and whether they say anything specific, and forms a view before a single statement is uploaded. A good document pack cannot rescue a site that reads like it is selling a treatment.

What holds up under that read:

• Product pages written as specifications rather than outcomes: what it is, purity and testing, handling, and nothing about what it does for a person. Compliance-safe product page copy goes through this line by line.
• Lab results displayed openly and tied to the batch, not a generic PDF buried in a footer. COA and lab-result page patterns covers the layouts that actually get read.
• Policy pages that commit to specifics, including real handling and delivery windows, who pays return shipping, and how to reach a human.
• Consistent framing everywhere, which is where most stores fail. The product page is careful, and then a blog post, a collection description, a popup or an old email template makes the claim the product page avoided.

That last point is worth an afternoon of your time. Search your own site for the handful of words a reviewer scans for, read every result, and fix the ones written before you understood the category. Stores get declined on copy they forgot was published.

Where CBD and supplement stores can process

Option	Fits	Watch for
Mainstream aggregator	Sometimes topicals or plain supplements, depending on the platform's current rules	Category reviews after approval and long holds on termination
High risk ISO or broker	Matching you with an acquirer that already carries your category	Ask which bank you are actually on
Direct high risk acquirer	Established stores with steady volume	Volume minimums and a full document pack
ACH and e-check	A backup rail when cards are refused or paused	Lower take-up than cards, so it is a bridge, not a replacement

Whichever you choose, get the category approval in writing. "CBD is fine" from a sales rep is not the same as an underwriter approving your actual catalog.

In practice that means a written confirmation that names what you sell, not the industry you are filed under. Ask which acquiring bank the account sits on, whether ingestibles are included or only topicals, and whether research-use items are in or out. Ask what happens to funds if the account is closed, and how long the reserve or hold runs. A broker who will not put those answers in an email is selling you an approval, not an account. The fast yes and the durable yes come from different places, and the difference only shows up months later. Choosing a payment processor walks through the questions that predict which one you got.

Keep disputes low from day one

Most CBD and supplement accounts that close do so because of disputes, not because of the category itself. A few habits make the biggest difference:

• Use a billing descriptor customers recognize, so a charge does not look like fraud on their statement. See descriptor optimization.
• Send order and shipping emails promptly, with tracking.
• Make refunds easy enough that a customer asks you before they ask their bank.
• Consider dispute alerts, which can let you refund before a dispute is filed. See chargeback alerts with Ethoca and RDR.
• Know the thresholds that put you in a monitoring program, covered in Visa VAMP and VDMP thresholds.

If you sell on subscription, the billing page is doing compliance work whether you designed it that way or not. State the renewal interval, the amount and the cancellation path on the same screen where the customer agrees to it. Hidden terms do not reduce cancellations, they convert them into disputes, which cost far more.

Run two accounts, not one

The approval is only the start. A single account is one review away from stopping all revenue, so plan an independent backup on a different bank and a gateway that can route between them.

The site has to be built for that too. If checkout is wired into one processor's proprietary blocks, swapping rails is a rebuild at the worst possible moment, with revenue stopped while you do it. Keeping the storefront processor-agnostic is what turns a termination into an afternoon of work instead of a crisis. Our guide on backup processor strategy covers the setup.

Practical takeaway

CBD and nutraceutical stores can get good merchant accounts, but not from whoever approves them fastest. The path that fails is the instant approval from a mainstream aggregator, a site written like a wellness brand, and one processor holding all the revenue. The path that lasts is plainly described products, lab documentation and policies in order, billing that never surprises a customer, an acquirer that has approved your exact catalog in writing, and a second account standing by before you need it. If you sell CBD, supplements, peptides or research compounds and want help building a store that holds up to that review, book a call.